Latest filing published 21 Nov 2014 for UROLOGIX INC.
No signal scores available.
Christopher R. Barys discloses dealings in Urologix Inc to SEC (Form 4). In total, 5 filings cover trades dated from 9 November 2010 to 6 November 2014.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 21 November 2014, reports a share grant in Urologix Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations